Abstract
In this project, we propose to evaluate the pharmacological interactions and possible synergistic effects of rifampin, isoniazid, amikacin, moxifloxacin, and five new furoxanic molecules obtained by the synthesis in LAPDESF (Laboratory of Drug Research and Development)at FCFAR/UNESP, which demonstrated promising against Mycobacterium tuberculosis. This project is part of the Young Researc…